Evidence map›Paper›PMID 19768600›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2009

High-throughput SNP genotyping: combining tag SNPs and molecular beacons.

Luis B Barreiro, Ricardo Henriques, Musa M Mhlanga

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Soybean BARCSoySNP6K: An assay for soybean genetics and breeding research.The Plant journal : for cell and molecular biology · 2020
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Luis B BarreiroDepartment of Human Genetics, The University of Chicago, Chicago, IL, USA.
Ricardo Henriques
Musa M Mhlanga

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decade, molecular beacons have emerged to become a widely used tool in the multiplex typing of single nucleotide polymorphisms (SNPs). Improvements in detection technologies in instrumentation and chemistries to label these probes have made it possible to use up to six spectrally distinguishable probes per reaction well. With the remarkable advances made in the characterization of human genome diversity, it has been possible to describe empirical patterns of SNPs and haplotype variation in the genome of diverse human populations. These patterns have revealed that the human genome is structured in blocks of strong linkage disequilibrium (LD). Because SNPs tend to be in LD with each other, common haplotypes share common SNPs and thus the majority of the diversity in a region can be characterized by typing a very small number of SNPs; so-called tag SNPs. Herein lies the advantage of the multiplexing ability of molecular beacons, since it becomes possible to use as few as 30 probes to interrogate several haplotypes in a high-throughput approach. Thus, through the combined use of tag SNPs and molecular beacons it becomes possible to type individuals for clinically relevant haplotypes in a high-throughput manner at a cost that is orders of magnitude less than that for high throughput sequencing methods.

Indexed as

Cell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinDNA PrimersFluorescent DyesGenetic LociGenotypeHigh-Throughput Screening AssaysHumansLectins, C-TypeMolecular ProbesPolymorphism, Single NucleotideReceptors, Cell SurfaceReverse Transcriptase Polymerase Chain ReactionCell Adhesion MoleculesDC-Specific ICAM-3 Grabbing NonintegrinDNA PrimersFluorescent DyesLectins, C-TypeMolecular ProbesReceptors, Cell Surface

Identifiers

PMID19768600
PMCPMC7121513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.